Efficacy and Tolerability of Erenumab in Patients With Trigeminal Neuralgia

NCT04054024 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Trigeminal Neuralgia

Interventions

DRUG: Erenumab
DRUG: Placebos

Sponsor

Danish Headache Center